EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Pheton Holdings's enterprise value is $55.08 Mil.
Pheton Holdings's Revenue for the trailing twelve months (TTM) ended in Jun. 2024 was $0.57 Mil. Therefore, Pheton Holdings's EV-to-Revenue for today is 96.29.
The historical rank and industry rank for Pheton Holdings's EV-to-Revenue or its related term are showing as below:
PTHL'
s EV-to-Revenue Range Over the Past 10 Years
Min: 26.35 Med: 29.31 Max: 39.78
Current: 96.29
During the past 3 years, the highest EV-to-Revenue of Pheton Holdings was 39.78. The lowest was 26.35. And the median was 29.31.
PTHL's EV-to-Revenue is ranked worse than 95.98% of 820
companies
in the Medical Devices & Instruments industry
Industry Median: 3.27
vs PTHL: 96.29
As of today (2025-01-18), Pheton Holdings's stock price is $3.84.
Pheton Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 was $0.07. Therefore, Pheton Holdings's PS Ratio for today is 56.47.
Pheton Holdings EV-to-Revenue Historical Data
The historical data trend for Pheton Holdings's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Pheton Holdings's EV-to-Revenue
For the Medical Devices subindustry, Pheton Holdings's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pheton Holdings's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Pheton Holdings's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Pheton Holdings's EV-to-Revenue falls into.
Pheton Holdings's current Enterprise Value is $55.08 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Pheton Holdings's Revenue for the trailing twelve months (TTM) ended in Jun. 2024 was $0.57 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pheton Holdings's share price for today is $3.84.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Jun. 2024 was $0.07.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pheton Holdings EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Pheton Holdings's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Pheton Holdings Ltd is a healthcare solutions provider dedicated to developing and commercializing treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a type of radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system, FTTPS, is designed to promote the efficiency, accuracy, and safety of brachytherapy. FTTPS is a user-oriented treatment planning system, or TPS, for treating a wide variety of malignant tumors, which can determine the target volume, prescription dose, and dose limitation to protect OARs and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PTHL has been successfully added to your